TWTamara Waldmann

Tamara Waldmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tamara Waldmann has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring the role of carers in psychiatric home treatment: qualitative multi-method study

    by Emma Kula, Marie Salzmann, Tamara Waldmann, Konstantinos Nikolaidis, Gerhard Längle, Peter Brieger, Jürgen Timm, Lasse Fischer, Svenja Raschmann, Martin Holzke, et al.

    Background: This qualitative study explored the roles, experiences, and needs of informal carers such as family and close friends in acute psychiatric home treatment in Germany. Methods: Data was collected through individual interviews, focus groups, and participant diaries with 27 carers and analyzed using grounded theory methodology. Results: The findings highlight the central yet multifaceted role carers play in facilitating care - initiating treatment, providing emotional containment, supporting daily functioning, and acting as intermediaries between service users and professionals. However, these roles were often poorly defined, leading to uncertainty, role conflicts, and occasional exclusion from the treatment process. Limited or unclear communication about expectations, responsibilities, and boundaries exacerbated this ambiguity. Carers also reported significant emotional and practical burdens, sometimes reaching a level of strain that jeopardized the continuation of home treatment. Recognition of their contributions, proactive engagement by the treatment team, and tailored support strategies were identified as key facilitators of positive involvement. Conclusions: The results underscore the need to systematically embed role clarification, structured collaboration, and carer support into the design and delivery of home treatment services. Future research should further explore how explicit clearly defined role negotiation and early joint planning meetings can enhance carer involvement while mitigating strain. Trial registration: German Clinical Trials Register (DRKS), DRKS00022476. Registered December 3 rd 2020, https://drks.de/search/de/trial/DRKS00022476 ; ClinicalTrials.gov, Identifier: NCT0474550. Registered February 9th 2021.

  • Open Access

    A comparison of the costs and patterns of expenditure for care for severe mental illness in five countries with different levels of economic development - CORRIGENDUM

    by A-La Park, Oliver Jez, Reinhold Kilian, Ashleigh Charles, Jasmine Kalha, Palak Korde, Max Lachmann, Candelaria Mahlke, Galia Moran, Juliet Nakku, et al.

  • Open Access

    A comparison of the costs and patterns of expenditure for care for severe mental illness in five countries with different levels of economic development

    by A-La Park, Oliver Jez, Reinhold Kilian, Ashleigh Charles, Jasmine Kalha, Palak Korde, Max Lachmann, Candelaria Mahlke, Galia Moran, Juliet Nakku, et al.

    Aims: The aim of the article is to undertake the first economic analysis exploring the costs of illness (COIs) and factors affecting COIs in people living with mental disorders using individual patient-level data across five countries with different national income levels. This is done by investigating diagnosis-related and sociodemographic factors for country-specific medical and psychosocial service use in these high, lower-middle and low-income countries. Methods: Using data from the Using Peer Support In Developing Empowering Mental Health Services (UPSIDES) study, a pragmatic randomized controlled trial, costs for medical and psychosocial services have been estimated over 6 months in 615 people with severe mental illness from Germany (n = 171), Uganda (n = 138), Tanzania (n = 110), India (n = 93) and Israel (n = 103). The primary economic analysis included (1) total COI expressed in 2021 international dollars and (2) proportional cost-type expenditures. Generalized linear regression models were also used to estimate the impact of psychiatric diagnosis, social disability, age and gender on the total COI. Results: Of the 615 participants (mean [SD] age 38.3 [11.2] years; 335 [54.5%] women), the total 6-month COI ranged from $311.48 [±547.47] in Tanzania to $10,493.19 [±13324.10] in Germany. High-income Germany and low-income Uganda both concentrated >70% of COIs on inpatient care. High-income Israel had the most balanced COI, with the lowest mean share (15.40%) on inpatient care, compared with community (35.12%) and primary care (33.01%). Female gender was associated with lower COI (eb = 0.215; p = 0.000) in Tanzania, while in India diagnosis of depression was associated with lower costs than schizophrenia (eb = 0.363; p = 0.017). Health of the Nation Outcome Scale scores (social disability) were not significantly associated with COIs in any country. In Tanzania, the total mean COI increased by 3.6% for every additional year of age. Compared to Germany, mean COIs were significantly lower by 90%, 99% and 86% in Uganda, Tanzania and India, respectively, and by 50% in Israel, although this difference was not significant. Conclusions: National income is correlated with the total COI in people living with mental disorders but is a poor predictor of the sector-specific distribution of these expenditures.


  • Open Access

    Effectiveness of peer support for people with severe mental health conditions in high-, middle- and low-income countries: multicentre randomised controlled trial

    by Bernd Puschner, Juliet Nakku, Ramona Hiltensperger, Philip Wolf, Inbar Adler Ben-Dor, Faith Bugeiga, Ashleigh Charles, Lion Gai Meir, Paula Garber-Epstein, Yael Goldfarb, et al.

    Background: Some trials have evaluated peer support for people with mental ill health in high-income, mainly English-speaking countries, but the quality of the evidence is weak. Aims: To investigate the effectiveness of UPSIDES peer support in high-, middle- and low-income countries. Method: This pragmatic multicentre parallel-group wait-list randomised controlled trial (registration: ISRCTN26008944) with three measurement points (baseline and 4 and 8 months) took place at six study sites: two in Germany, and one each in Uganda, Tanzania, Israel and India. Participants were adults with long-standing severe mental health conditions. Outcomes were improvements in social inclusion (primary) and empowerment, hope, recovery, health and social functioning (secondary). Participants allocated to the intervention group were offered UPSIDES peer support. Results: Of the 615 participants (305 intervention group), 337 (54.8%) identified as women. The average age was 38.3 (s.d. = 11.2) years, and the mean illness duration was 14.9 (s.d. = 38.4) years. Those allocated to the intervention group received 6.9 (s.d. = 4.2) peer support sessions on average. Intention-to-treat analysis showed effects on two of the three subscales of the Social Inclusion Scale, Empowerment Scale and HOPE Scale. Per-protocol analysis with participants who had received three or more intervention sessions also showed an effect on the Social Inclusion Scale total score ( β = 0.18, P = 0.031, 95% CI: 0.02–0.34). Conclusions: Peer support has beneficial impacts on social inclusion, empowerment and hope among people with severe mental health conditions across diverse settings. As social isolation is a key driver of mental ill health, and empowerment and hope are both crucial for recovery, peer support can be recommended as an effective component of mental healthcare. Peer support has the potential to move global mental health closer towards a recovery- and rights-based orientation.


  • Open Access

    The cost-utility of a return-to-work intervention in comparison to routine care for patients with mental disorders in Germany: Results from the RETURN project

    by Tamara Waldmann, Lina Riedl, Peter Brieger, Anne Lang, Daniela Blank, Monika Kohl, Adele Brucks, Markus Bühner, Johannes Hamann, Reinhold Kilian

    Background: Only two-thirds of patients admitted to psychiatric wards return to their previous jobs. Return-to-work interventions in Germany are investigated for their effectiveness, but information regarding cost-effectiveness is lacking. This study investigates the cost-utility of a return-to-work intervention for patients with mental disorders compared to treatment as usual (TAU). Methods: We used data from a cluster-randomised controlled trial including 166 patients from 28 inpatient psychiatric wards providing data at 6- and 12-month follow-ups. Health and social care service use was measured with the Client Sociodemographic and Service Receipt Inventory. Quality of life was measured with the EQ-5D-3L questionnaire. Cost-utility analysis was performed by calculating additional costs per one additional QALY (Quality-Adjusted Life Years) gained by receiving the support of return-to-work experts, in comparison to TAU. Results: No significant cost or QALY difference between the intervention and control groups has been detected. The return-to-work intervention cannot be identified as cost-effective in comparison to TAU. Conclusions: The employment of return-to-work experts could not reach the threshold of providing good value for money. TAU, therefore, seems to be sufficient support for the target group.


  • Open Access

    Supporting return to work after psychiatric hospitalization—A cluster randomized study (RETURN-study)

    by Johannes Hamann, Anne Lang, Lina Riedl, Daniela Blank, Monika Kohl, Adele Brucks, David Goretzko, Markus Bühner, Tamara Waldmann, Reinhold Kilian, et al.

    Background: If people with episodic mental-health conditions lose their job due to an episode of their mental illness, they often experience personal negative consequences. Therefore, reintegration after sick leave is critical to avoid unfavorable courses of disease, longer inability to work, long payment of sickness benefits, and unemployment. Existing return-to-work (RTW) programs have mainly focused on “common mental disorders” and often used very elaborate and costly interventions without yielding convincing effects. It was the aim of the RETURN study to evaluate an easy-to-implement RTW intervention specifically addressing persons with mental illnesses being so severe that they require inpatient treatment. Methods: The RETURN study was a multi-center, cluster-randomized controlled trial in acute psychiatric wards addressing inpatients suffering from a psychiatric disorder. In intervention wards, case managers (RTW experts) were introduced who supported patients in their RTW process, while in control wards treatment, as usual, was continued. Results: A total of 268 patients were recruited for the trial. Patients in the intervention group had more often returned to their workplace at 6 and 12 months, which was also mirrored in more days at work. These group differences were statistically significant at 6 months. However, for the main outcome (days at work at 12 months), differences were no longer statistically significant (p = 0.14). Intervention patients returned to their workplace earlier than patients in the control group (p = 0.040). Conclusions: The RETURN intervention has shown the potential of case-management interventions when addressing RTW. Further analyses, especially the qualitative ones, may help to better understand limitations and potential areas for improvement.


    • 1 March 2021
      • Vol. 24  (1) , 31-41

    Costs of Health Service Use among Unemployed and Underemployed People with Mental Health Problems

    by Tamara Waldmann, Tobias Staiger, Nicolas Ruesch, Reinhold Kilian

    Background: Unemployment is associated with a high risk of experiencing mental illness. This can lead to stigmatisation, reduced quality of life, and long-term costs like increased healthcare expenditure and productivity losses for society as a whole. Previous research indicates evidence for an association between unemployment and higher mental health service costs, but there is insufficient information available for the German healthcare system. Aim of the Study: This study aims to identify costs and cost drivers for health and social service use among unemployed people with mental health problems in Germany. Methods: A sample of 270 persons participated at baseline and six-month-follow-up. Healthcare and social service use was assessed using the Client Socio-Demographic and Service Receipt Inventory. Descriptive cost analysis was performed. Associations between costs and potential cost drivers were tested using structural equation modelling. Results: Direct mean costs for 12 months range from (sic)1265.13 (somatic costs) to (sic)2206.38 (psychiatric costs) to (sic)3020.70 (total costs) per person. Path coefficients indicate direct positive effects from the latent variable mental health burden (MHB) on stigma stress, somatic symptoms, and sick leave. Discussion: The hypothesis that unemployed people with mental health problems seek help for somatic symptoms rather than psychiatric symptoms was not supported. Associations between MHB and costs strongly mediated by sick leave indicate a central function of healthcare provision as being confirmation of the inability to work. Implications for Health Policies: Targeted interventions to ensure early help-seeking and reduce stigma remain of key importance in reducing long-term societal costs. Implications for Further Research: Future research should explore attitudes regarding effective treatment for the target group.


  • Open Access

    Costs of health and social services use in children of parents with mental illness

    by Tamara Waldmann, Maja Stiawa, Ümügülsüm Dinc, Gülsah Saglam, Mareike Busmann, Anne Daubmann, Bonnie Adema, Karl Wegscheider, Silke Wiegand-Grefe, Reinhold Kilian

    Background: Children of parents with mental illness have a higher risk of developing mental health problems when compared with the general population. Therefore, families with parents with mental illness are a suitable target group for selective prevention. In order to plan and evaluate the health economic consequences of preventive interventions for this target group, data on the societal costs related to parenthood under the condition of mental disorders are needed. To date, within Germany there has been a lack of research evaluating the costs of mental health treatment and use of social services by children and adolescents with parents with mental illness. Methods: As part of a multicentre randomised controlled trial, use and costs of health and social services were assessed for a sample of 332 children and adolescents with parents with mental illness in six regions of Germany. Service use at baseline was assessed by the German version of the Children and Adolescent Mental Health Service Receipt Inventory. Costs were calculated for 12 months based on diagnosis and service user status and described separately. Cost drivers were identified by means of a two-part regression model. Results: Total mean costs for 12 months for the total sample amount of € 3736.35 (95% CI: € 2816.84–4813.83) per person. Children with a psychiatric diagnosis generated a total of € 5691.93 (95% CI: € 4146.27–7451.38) of costs per person, compared to € 1245.01 (95% CI: € 657.44–1871.49) for children without a psychiatric diagnosis. The logit part indicates significant odds ratios for individual functioning and diagnosis of the child as well as for family functioning. The linear part reveals that increasing individual functioning in the child is related to decreasing costs. Conclusions: Children of families with parents with mental illness use a broad spectrum of mental health care, school-based support and youth welfare services even if they are not yet diagnosed as having a mental disorder. Further research should examine whether these institutions are sufficiently qualified and interlinked to meet the support needs of this vulnerable group. Trial registration The study was registered at the 07/10/2014 before the start of data collection (04/11/2014) at the German clinical trials register (Deutsches Register Klinischer Studien, DRKS, nr: DRKS00006806, https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00006806).